Prevalence, Management and Follow-up of Patients With Addiction to Opioid Analgesics

Analgesics Grade 2's Addiction Clinical Trial

Official title:

Prevalence, Management and Follow-up of Patients With Addiction to Opioid Analgesics

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03297853
• Other study ID #: RECHMPL17_0305
• Status: Completed
• Start date: January 1, 2014
• Est. completion date: March 30, 2018

Study information

• Verified date: September 2017
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The demand for addiction care for patients with addiction to analgesics increases with the number of prescription of analgesics grade 2; this is a public health problem There is no support for repositories to date in the context of addiction analgesics grade 2.

Risk factors of misuse as well as diagnostic tools were identified.

Description:

The demand for addiction care for patients with addiction to analgesics increases with the number of prescription of analgesics grade 2; this is a public health problem There is no support for repositories to date in the context of addiction analgesics grade 2.

Risk factors of misuse as well as diagnostic tools were identified. The objectives of our research are to determine the characteristics of the individuals suffering from an addiction to analgesics of level 2 followed in consultation of addictology in the hospital of Montpellier and Nimes and to describe the type of follow-up proposed to the patients in these two centers. It is a retrospective and descriptive study.

As part of this research, we will solicit all the patients followed in consultation of addictology or in hospitalization to the hospital of Montpellier or Nîmes for an addiction to the analgesics of grade 2 between the 1st of January 2014 and the 10th of July 2017 with requests of management for withdrawal or reduction of doses, opioid analgesics in the absence of pain or in chronic non-cancer pain, opioid analgesics to avoid withdrawal syndrome or hyperalgesia and consumptions chronic to dosages inadequate to the functional complaint evaluated by the rhumatology or algology services.

The data are collected in the medical file at the two participating institutions (Montpellier and Nîmes) and if necessary, patients not seen in consultation for more than 6 months will be recontacted.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 64
• Est. completion date: March 30, 2018
• Est. primary completion date: July 31, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Requests for management for weaning or reduction of doses

• Take opioid analgesics in the absence of pain or as part of chronic non-cancer pain

• Opioid analgesics to prevent withdrawal syndrome or hyperalgesia

• Chronic consumption at inadequate dosages compared to the functional complaint evaluated by the MPR / Algologie services

• Patients over 18 years and who agree with the study

Exclusion criteria:

• language barrier

• severe cognitive and / or psychiatric disorders

Related Conditions & MeSH terms

• Analgesics Grade 2's Addiction
• Behavior, Addictive

Locations

Country	Name	City	State
France	Uhmontpellier	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	50/5000 Prevalence of demand for care in addictology	Prevalence of demand for addictive care in subjects with addiction to analgesics in level 2	1 day
Secondary	Types of support proposed	Types of support proposed	1 day
Secondary	Assessment of analgesic dependence	Assessment of analgesic dependence	1 day
Secondary	History of analgesic use	History of analgesic use	1 day
Secondary	quality of life	quality of life	1 day